Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
18.5M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
+2.19M
-
Total reported value, excl. options
-
$486M
-
Value change
-
+$101M
-
Put/Call ratio
-
1.38
-
Number of buys
-
62
-
Number of sells
-
-38
-
Price
-
$45.25
Significant Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q2 2024
128 filings reported holding CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 18.5M outstanding shares and own 58.04% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (2.03M shares), BlackRock Inc. (761K shares), VANGUARD GROUP INC (585K shares), Octagon Capital Advisors LP (488K shares), STATE STREET CORP (442K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (400K shares), CITADEL ADVISORS LLC (333K shares), Darwin Global Management, Ltd. (325K shares), Ikarian Capital, LLC (310K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (302K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.